Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) soared at $3.51, representing a gain of 92.9%. On Mon, Mar 06, 2023, BLPH:NASDAQ touched a New 2-Week High of $3.51. The stock got featured on our News Catalysts scanner on Thu, Feb 09, 2023 at 09:43 AM in the 'BIOTECH' category. From Tue, Feb 21, 2023, the stock recorded 44.44% Up Days and 60.00% Green Days
The stock spiked on Mon, Mar 06, 2023 at $5.12 with a volume of 34M+.
About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.
Top 10 Gainers:
- Appreciate Holdings Inc Cl A (SFR:NASDAQ), 159.32%
- Unicycive Therapeutics Inc. (UNCY:NASDAQ), 153.06%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 95.02%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 92.86%
- Genelux Corporation (GNLX:NASDAQ), 60.42%
- Orchestra BioMed Holdings Inc Com (OBIO:NASDAQ), 58.09%
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 54.64%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 53.92%
- BridgeBio Pharma, Inc. (BBIO:NASDAQ), 51.98%
- Troika Media Group Inc. (TRKA:NASDAQ), 48.64%